Navigation Links
Male sex hormones in ovaries essential for female fertility
Date:5/26/2010

Male sex hormones, such as testosterone, have well defined roles in male reproduction and prostate cancer. What may surprise many is that they also play an important role in female fertility. A new study finds that the presence and activity of male sex hormones in the ovaries helps regulate female fertility, likely by controlling follicle growth and development and preventing deterioration of follicles that contain growing eggs.

This study and others highlight the fact that women need certain levels of male hormones, or androgens, in their bodies to function normally. The current study, published today in the journal Molecular Endocrinology, points to irregular androgen levels in the ovaries of female mice as a major cause of infertility. Understanding how male hormones influence ovulation in mice may provide clues as to how to better regulate androgens and combat infertility in humans.

"The need for certain levels of male hormones in the female body and the strong influence these hormones have is often underappreciated," said Stephen Hammes, M.D., Ph.D., Louis S. Wolk Distinguished Professorship in Medicine (Endocrinology and Metabolism) at the University of Rochester Medical Center and a lead author of the study. "Our findings open up a new line of research into how we can regulate male sex hormones, specifically in the ovaries, to improve fertility."

These findings are relevant to women who suffer from polycystic ovarian syndrome (PCOS), a condition characterized by androgen excess. PCOS is marked by the overproduction of male hormones and causes ovarian changes that prohibit regular ovulation, often contributing to infertility. Hammes, chief of the Division of Endocrinology and Metabolism at the University of Rochester, believes that better understanding the overall effects of androgen levels in the ovary may help researchers determine how to target and control the increased levels that lead to fertility problems in women with PCOS.

Polycystic ovarian syndrome is the No. 1 cause of infertility in women. The condition affects 5 percent to 10 percent of women of childbearing age and is nearly as common as (and often associated with) Type 2 diabetes. Overall, more than 6.1 million women in the United States ages 15 to 44 have difficulty getting pregnant or staying pregnant, according to the Centers for Disease Control and Prevention.

The current research builds on past studies, some of which were performed in the laboratory of Chawnshang Chang, Ph.D., at the University of Rochester, which have shown that completely eliminating male hormone receptors, or androgen receptors, in female mice leads to abnormal ovarian function and reduced fertility. To help determine which reproductive tissues, including the hypothalamus, pituitary, and many cells within the ovary, regulate fertility, authors of the current study removed androgen receptors from only ovarian cells, known as granulosa cells, in female mice. Androgen receptors in all other reproductive tissues, including the hypothalamus, pituitary, and other ovarian cells were left intact.

Female mice without androgen receptors in the ovarian granulosa cells had premature ovarian failure, meaning they stopped ovulating too early, and were sub-fertile, meaning they had abnormal ovulation cycles, did not ovulate as many eggs as control mice, and had smaller litter sizes. These mice also had fewer follicles that completed development and were ready to ovulate; rather, many of their follicles did not progress beyond pre-development stages and died before ovulation could occur.

These results suggest that the presence of male hormones in ovarian granulosa cells in mice is critical for normal follicle development and fertility. When androgen receptor signaling is blocked or eliminated in ovarian granulosa cells, ovarian follicles cannot progress to later stages of development, ultimately resulting in reduced fertility.

"We found that fertility problems are most likely present because androgen signaling in the ovary is abnormal," said Aritro Sen, Ph.D., research assistant professor in the division of Endocrinology and Metabolism at the University of Rochester Medical Center and a lead author of the study. "Previously, we assumed that androgen signaling in the brain the hypothalamus and the pituitary was at the root of the problem, but we found that is not the case."


'/>"/>

Contact: Emily Butler
emily_butler@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
2. Demonstrated in vivo the transfer of maternal thyroid hormones to the fetus
3. Anti-aging hormones: Little or no benefit and the risks are high
4. Hormones Tied to Diabetes Might Also Influence Fertility
5. New study questions benefits of elective removal of ovaries during hysterectomy
6. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
7. Brain Thermostat May Suppress Non-Essential Information
8. Wiley-Blackwell launches new online medical reference tool -- Essential Evidence
9. Bishops Call Senate Health Care Reform Bill Deficient, Essential Changes Needed Before Moving Forward
10. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
11. Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of ... collection of specialty vendors and unique items from across the nation, this holiday-themed event ... wellness services offered by the VNA. The boutique will be open Saturday, November ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: